For Hollings Members

Hollings members are a collaborative group who work across disciplines with one mission in mind – easing the burden of cancer in South Carolina and beyond. Members include physician scientists, basic scientists, population scientists, nurse scientists and more.

Become a Member

Looking over the shoulder of someone peering through a microscope.

Pages in this Section

Advancing discovery together

Hollings and the greater MUSC research community have resources to help you to develop your research skills, access funding, conduct transdisciplinary science and move findings from the lab to the clinic.

Member Resources

Become a Member

Faculty members with an interest in cancer care and research are encouraged to apply.

Intramural Funding Opportunities

Hollings supports innovative research ideas from postdoctoral trainees and faculty.

For Clinical Trial Investigators

The Clinical Trials Office is ready to assist you in writing and opening clinical trials.

Shared Resources

Shared Resources provide access to sophisticated imaging and analytical equipment and expertise.

Transdisciplinary Cancer Teams

Our TCTs bring basic scientists, clinicians and population scientists together to focus on a single cancer type.

SC SPOT

This database pulls information from multiple sources, localizing it to South Carolina counties.

Distinguished Lecture Series

This monthly event brings leading researchers from around the country to Hollings.

High Impact Publications Award

Hollings leadership annually recognizes researchers who have published exceptional work.

Find a Researcher

Hollings members include clinicians, basic scientists, biostatisticians and population scientists.

Member Spotlight

Illustration. A young person stares mesmerized at a smartphone as rewards from their smart vape pile up.

Dangerous combo

In a perspective in the New England Journal of Medicine, Hollings researchers sound the alarm about new 'smart vapes' that mix gamification and financial rewards with vaping.

Read what they say

Rates of Treatment

Research by Adam Fox, M.D., and Gerard Silvestri, M.D., on rates of systemic treatment for people with metastatic non-small-cell lung cancer was featured in the New York Times.

Read the story on the New York Times website

Two doctors in button-down shirts open at the collar & stethoscopes around their necks pose in a clinic hall

A man holds an award on stage, flanked by two people, in front of a sign that says Cancer Prevention Research Conference with the logos of the American Cancer Society and Cancer Research UK.

Cancer Prevention Honor

Hollings director Raymond N. DuBois, M.D., Ph.D., was honored with the 2026 Cancer Prevention Research Outstanding Achievement Award at the 3rd annual Cancer Prevention Research Conference, hosted by the American Cancer Society and Cancer Research UK.

Read an interview with Dr. DuBois about this award

ASCO Champion

Abirami Sivapiragasam (Abi Siva), M.D., was named an ASCO Advocacy Champion. Advocacy Champions are Association for Clinical Oncology (ASCO) volunteers who have made meaningful contributions to the Association’s advocacy activities throughout the year to ensure that every patient with cancer has access to high-quality cancer care no matter who they are or where they live.

Craig Lockhart in suit and tie leans against a pillar in the garden.

Treatment Decisions

Craig Lockhart, M.D., discusses the evolution of first-line systemic therapy for hepatocellular carcinoma (HCC) and how he selects therapies for patients with different comorbidities.

Watch the BackTable Tumor Board

ASCO Roles

Evan Graboyes, M.D., has been selected to serve as a member of the American Society of Clinical Oncology (ASCO) Head and Neck Cancer Guidelines Advisory Group and as chair of the ASCO Health Policy Committee.

A surgeon poses in an empty operating room.

Find a Researcher

Cancer Registry Data

The MUSC Central Cancer Registry collects data on cancer patients from all facilities within the health system. This data is submitted to the National Cancer Database, the SC Central Cancer Registry, and utilized internally for quality improvement, research and administrative purposes. This data from the Cancer Registry is the foundation of our accreditations with the American College of Surgeons (CoC, NAPBC and NAPRC), our designation as an NCI-Designated Cancer Center, and many of our research initiatives.

Clinicians, researchers, administrators and other stakeholders may request data from the Cancer Registry to assist with their work. Using the link below, users can request data for QI projects, clinical trial feasibility, administrative needs and more. Once the form is completed, a member of the Cancer Registry team will reach out to schedule a follow-up discussion on building your report.

Request Cancer Registry data

If you have IRB-approved data needs, please complete a CIDER request for access to the same data.

Request data from CIDER